121 related articles for article (PubMed ID: 37815793)
1. Association Between Serum Chemokine Ligand 20 Levels and Disease Activity and Th1/Th2/Th17-Related Cytokine Levels in Rheumatoid Arthritis.
Wang L; Hong X; Du H
J Interferon Cytokine Res; 2023 Nov; 43(11):512-517. PubMed ID: 37815793
[TBL] [Abstract][Full Text] [Related]
2. T helper cells in synovial fluid of patients with rheumatoid arthritis primarily have a Th1 and a CXCR3
Aldridge J; Ekwall AH; Mark L; Bergström B; Andersson K; Gjertsson I; Lundell AC; Rudin A
Arthritis Res Ther; 2020 Oct; 22(1):245. PubMed ID: 33066816
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis.
Kim J; Kang S; Kim J; Kwon G; Koo S
Ann Lab Med; 2013 Jan; 33(1):52-9. PubMed ID: 23301223
[TBL] [Abstract][Full Text] [Related]
4. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis.
Miao J; Zhang K; Lv M; Li Q; Zheng Z; Han Q; Guo N; Fan C; Zhu P
Scand J Rheumatol; 2014; 43(3):194-201. PubMed ID: 24392804
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between serum CCL20 level and disease severity in patients with rheumatoid arthritis].
Du LY; Zhang MJ; Liu PF; Xiao G; Lyu XM
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Feb; 55(2):226-232. PubMed ID: 34645184
[No Abstract] [Full Text] [Related]
6. Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis.
Lina C; Conghua W; Nan L; Ping Z
J Clin Immunol; 2011 Aug; 31(4):596-605. PubMed ID: 21562776
[TBL] [Abstract][Full Text] [Related]
7. Serum IL-35 is decreased in overweight patients with rheumatoid arthritis: its correlation with Th1/Th2/Th17-related cytokines.
Li Y; Jie Y; Wang X; Lu J
BMC Immunol; 2021 Jun; 22(1):42. PubMed ID: 34176464
[TBL] [Abstract][Full Text] [Related]
8. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
9. The relationship of blood CDC42 level with Th1 cells, Th17 cells, inflammation markers, disease risk/activity, and treatment efficacy of rheumatoid arthritis.
Li Y; Yang W; Wang F
Ir J Med Sci; 2022 Oct; 191(5):2155-2161. PubMed ID: 34859333
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
11. Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis.
Melis L; Vandooren B; Kruithof E; Jacques P; De Vos M; Mielants H; Verbruggen G; De Keyser F; Elewaut D
Ann Rheum Dis; 2010 Mar; 69(3):618-23. PubMed ID: 19196728
[TBL] [Abstract][Full Text] [Related]
12. Th1-Th17 Ratio as a New Insight in Rheumatoid Arthritis Disease.
Bazzazi H; Aghaei M; Memarian A; Asgarian-Omran H; Behnampour N; Yazdani Y
Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):68-77. PubMed ID: 29512371
[TBL] [Abstract][Full Text] [Related]
13. Serum amyloid A/anti-CCL20 induced the rebalance of Th17/regulatory T cells in SodA-induced sarcoidosis.
Meng K; Zhang B; Ma C; Dai Q; Gui X; Liu X; Zhao Q; Gao Q; Wen Y; Ding J
Int Immunopharmacol; 2022 Aug; 109():108784. PubMed ID: 35461156
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
15. MALT1 regulates Th2 and Th17 differentiation
Wang Q; Wang Y; Liu Q; Chu Y; Mi R; Jiang F; Zhao J; Hu K; Luo R; Feng Y; Lee H; Zhou D; Mi J; Deng R
Front Immunol; 2022; 13():913830. PubMed ID: 35967391
[TBL] [Abstract][Full Text] [Related]
16. Circulating PCSK9 relates to aggravated disease activity, Th17/Treg imbalance, and predicts treatment outcome of conventional synthetic DMARDs in rheumatoid arthritis patients.
Meng Y; Zheng X; Zhang Z; Geng H; Li X
Ir J Med Sci; 2023 Dec; 192(6):3187-3194. PubMed ID: 36826711
[TBL] [Abstract][Full Text] [Related]
17. Altered T cell plasticity favours Th17 cells in early arthritis.
Leipe J; Pirronello F; Schulze-Koops H; Skapenko A
Rheumatology (Oxford); 2020 Oct; 59(10):2754-2763. PubMed ID: 32030419
[TBL] [Abstract][Full Text] [Related]
18. The Expression of P2X7 Receptor on Th1, Th17, and Regulatory T Cells in Patients with Systemic Lupus Erythematosus or Rheumatoid Arthritis and Its Correlations with Active Disease.
Li M; Yang C; Wang Y; Song W; Jia L; Peng X; Zhao R
J Immunol; 2020 Oct; 205(7):1752-1762. PubMed ID: 32868411
[TBL] [Abstract][Full Text] [Related]
19. Blood MALT1, Th1, and Th17 cells are dysregulated, inter-correlated, and correlated with disease activity in rheumatoid arthritis patients; meanwhile, MALT1 decline during therapy relates to treatment outcome.
Ye Z; Chen L; Fang Y; Zhao L
J Clin Lab Anal; 2022 Jan; 36(1):e24112. PubMed ID: 34788483
[TBL] [Abstract][Full Text] [Related]
20. Intra-articular CD1c-expressing myeloid dendritic cells from rheumatoid arthritis patients express a unique set of T cell-attracting chemokines and spontaneously induce Th1, Th17 and Th2 cell activity.
Moret FM; Hack CE; van der Wurff-Jacobs KM; de Jager W; Radstake TR; Lafeber FP; van Roon JA
Arthritis Res Ther; 2013 Oct; 15(5):R155. PubMed ID: 24286358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
